The CBD Swiss Dream is ready for the market after a long period of research & development. This is a high strain of CBD cannabis that has an approximate 26:1 CBD:THC ratio!
THC concentrations are consistently below 0.25%, while CBD is measured at 7% . The result is a cannabis plant with psycho-activity levels virtually non-existent, a boon for many patients with medical marijuana.
Swiss Dream CBD is an indica-dominant hybrid that, somewhat unusually, was only produced in a continuous selection process without the use of 'industrial hemp' plants using elite strains in order to detect pheno-types with reliably low THC and high CBD levels.
Swiss Dream CBD is very sativa-like visually and structurally, and this translates into its hardiness and resistance to pests as well as its adaptability to both indoor and outdoor conditions where they can fall below the ideal.
It can develop into a very bushy plant with masses of inner internodes, so it is recommended to thin the inner branches not only to concentrate the energy of the plant on its outer buds, but also to encourage good airflow through the innermost branches and leaves of the plant.
The leaves are unusually olive green and the buds are compact and tight with a bullet-shaped shape. While its flavour has both diesel fuel and ginger notes, the perfume is floral and spicy.
The yields are very good; 550 - 600 gr/m2 should be produced by indoor plants during a flowering time of 70 - 75 days. These plants can reach a height of 200 cm outdoors. Producing yields of 800 gr/plant with harvests from the northern hemisphere during the month of October.
After consuming this variety, patients will remain completely lucid, but its effect is ultimate muscle relaxation, which is an intoxicating prospect for those suffering in that region.